Latest News
![](https://lagunatechmed.com/wp-content/uploads/2024/03/PR3.jpg)
Laguna Tech USA Announces Site Record Number of Transcatheter Heart Valves Implanted at Single Center on Same Day in First-in-Human Clinical Trial
RVINE, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) — Laguna Tech USA, a privately-held medical technology company dedicated to innovations in structural heart solutions to broaden
![](https://lagunatechmed.com/wp-content/uploads/2024/03/PR2.jpg)
Laguna Tech USA Announces Newly Designed Heart Valves with Advanced Engineering Successfully Implanted in First-in-Human Clinical Trial
IRVINE, Calif., Oct. 24, 2023 (GLOBE NEWSWIRE) — Laguna Tech USA, a privately-held medical technology company dedicated to innovations in structural heart solutions to broaden
![](https://lagunatechmed.com/wp-content/uploads/2024/03/PR1.jpg)
Laguna Tech USA Begins FIH Trial of Alpha TAVR System
June 21, 2023—Laguna Tech USA announced that the first patient has been treated in the first-in-human clinical trial of the company’s investigational Alpha transcatheter aortic
![](https://lagunatechmed.com/wp-content/uploads/2023/02/pat2.jpg)
Laguna Tech USA announces Patent
Laguna Tech USA announces Patent Granted by USPTO (US 11,806,233), Strengthening the Company’s Intellectual Property Position in the crowded TAVR Market For more information contact